|
DK0988038T3
(da)
|
1997-06-02 |
2002-12-02 |
Janssen Pharmaceutica Nv |
Anvendelse af (imidazol-5-yl)methyl-2-quinolinon derivater til hæmning af glat muskelcelleproliferation
|
|
US20030040790A1
(en)
*
|
1998-04-15 |
2003-02-27 |
Furst Joseph G. |
Stent coating
|
|
US20020099438A1
(en)
*
|
1998-04-15 |
2002-07-25 |
Furst Joseph G. |
Irradiated stent coating
|
|
HRP20000904A2
(en)
*
|
1998-07-06 |
2001-12-31 |
Janssen Pharmaceutica Nv |
Farnesyl protein transferase inhibitors for treating arthropathies
|
|
US7967855B2
(en)
|
1998-07-27 |
2011-06-28 |
Icon Interventional Systems, Inc. |
Coated medical device
|
|
US8070796B2
(en)
|
1998-07-27 |
2011-12-06 |
Icon Interventional Systems, Inc. |
Thrombosis inhibiting graft
|
|
BR9913315A
(pt)
*
|
1998-08-27 |
2001-05-22 |
Pfizer Prod Inc |
Derivados de quinolin-2-ona úteis como agentes anticâncer
|
|
HU229404B1
(en)
*
|
1998-12-23 |
2013-12-30 |
Janssen Pharmaceutica Nv |
1,2-annelated quinoline derivatives
|
|
ID29584A
(id)
|
1999-02-11 |
2001-09-06 |
Pfizer Prod Inc |
Turunan-turunan kuinolin-2-on tersubstitusi heteroaril yang bermanfaat sebagai zat-zat anti kanker
|
|
ES2212971T3
(es)
|
1999-11-30 |
2004-08-16 |
Pfizer Products Inc. |
Derivados de quinolina utiles para la inhibicion de la farnesil protein transferasa.
|
|
US6844357B2
(en)
*
|
2000-05-01 |
2005-01-18 |
Pfizer Inc. |
Substituted quinolin-2-one derivatives useful as antiproliferative agents
|
|
JO2361B1
(en)
|
2000-06-22 |
2006-12-12 |
جانسين فارماسيوتيكا ان. في |
Enaniumer 1,2-anylated quinoline inhibitor for the transporter - farnesyl
|
|
ES2302106T3
(es)
|
2000-09-11 |
2008-07-01 |
Novartis Vaccines And Diagnostics, Inc. |
Procedimiento de preparacion de derivados de bencimidazol-2-il quinolina.
|
|
FR2813791B1
(fr)
*
|
2000-09-14 |
2004-03-12 |
Lafon Labor |
Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
|
|
AU2001293835A1
(en)
*
|
2000-09-25 |
2002-04-02 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
|
|
JP4974438B2
(ja)
|
2000-09-25 |
2012-07-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ファルネシルトランスフェラーゼを阻害する６−ヘテロシクリルメチルキノリンおよびキナゾリン誘導体
|
|
AU2001293826A1
(en)
|
2000-09-25 |
2002-04-02 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
|
|
WO2002024683A1
(en)
*
|
2000-09-25 |
2002-03-28 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives
|
|
WO2002042296A1
(en)
|
2000-11-21 |
2002-05-30 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting benzoheterocyclic derivatives
|
|
EP1347966B1
(en)
|
2000-12-27 |
2006-03-08 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
|
|
WO2003000266A1
(en)
|
2001-06-21 |
2003-01-03 |
Ariad Pharmaceuticals, Inc. |
Novel quinolines and uses thereof
|
|
CA2469275C
(en)
|
2001-12-19 |
2011-09-06 |
Janssen Pharmaceutica N.V. |
1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors
|
|
US7354932B2
(en)
|
2001-12-21 |
2008-04-08 |
Anormed, Inc. |
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
|
|
ATE364384T1
(de)
|
2002-03-22 |
2007-07-15 |
Janssen Pharmaceutica Nv |
Benzylimidazolyl substituierte 2-chinolon und chinazolinon derivate zur verwendung als farnesyl transferase inhibitoren
|
|
ATE336496T1
(de)
|
2002-04-15 |
2006-09-15 |
Janssen Pharmaceutica Nv |
Farnesyl transferase hemmende tricyclische quinazolinederivate substitutiert mit kohlenstoff-gebundenen imidazolen oder triazolen
|
|
US8016881B2
(en)
|
2002-07-31 |
2011-09-13 |
Icon Interventional Systems, Inc. |
Sutures and surgical staples for anastamoses, wound closures, and surgical closures
|
|
US7825132B2
(en)
|
2002-08-23 |
2010-11-02 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibition of FGFR3 and treatment of multiple myeloma
|
|
US6638301B1
(en)
*
|
2002-10-02 |
2003-10-28 |
Scimed Life Systems, Inc. |
Medical device with radiopacity
|
|
SG148864A1
(en)
|
2002-11-13 |
2009-01-29 |
Chiron Corp |
Methods of treating cancer and related methods
|
|
US20050154451A1
(en)
*
|
2003-12-18 |
2005-07-14 |
Medtronic Vascular, Inc. |
Medical devices to treat or inhibit restenosis
|
|
WO2005070924A1
(en)
*
|
2004-01-23 |
2005-08-04 |
Janssen Pharmaceutica N.V. |
Substituted quinolines and their use as mycobacterial inhibitors
|
|
US7211108B2
(en)
*
|
2004-01-23 |
2007-05-01 |
Icon Medical Corp. |
Vascular grafts with amphiphilic block copolymer coatings
|
|
WO2005082340A2
(en)
|
2004-02-20 |
2005-09-09 |
Chiron Corporation |
Modulation of inflammatory and metastatic processes
|
|
RU2006136381A
(ru)
*
|
2004-03-15 |
2008-04-27 |
Анормед, Инк. (Ca) |
Способ получения антагониста cxcr4
|
|
US20060106060A1
(en)
*
|
2004-03-18 |
2006-05-18 |
The Brigham And Women's Hospital, Inc. |
Methods for the treatment of synucleinopathies (Lansbury)
|
|
JP2007529555A
(ja)
*
|
2004-03-18 |
2007-10-25 |
ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド |
シヌクレイノパチーを治療する方法
|
|
US20070293539A1
(en)
*
|
2004-03-18 |
2007-12-20 |
Lansbury Peter T |
Methods for the treatment of synucleinopathies
|
|
US20050272068A1
(en)
*
|
2004-03-18 |
2005-12-08 |
The Brigham And Women's Hospital, Inc. |
UCH-L1 expression and cancer therapy
|
|
EP1744751A4
(en)
*
|
2004-03-18 |
2010-03-10 |
Brigham & Womens Hospital |
METHOD FOR THE TREATMENT OF SYNUCLEINOPATHIES
|
|
US20050272722A1
(en)
*
|
2004-03-18 |
2005-12-08 |
The Brigham And Women's Hospital, Inc. |
Methods for the treatment of synucleinopathies
|
|
US7063720B2
(en)
*
|
2004-09-14 |
2006-06-20 |
The Wallace Enterprises, Inc. |
Covered stent with controlled therapeutic agent diffusion
|
|
US20060083770A1
(en)
*
|
2004-10-15 |
2006-04-20 |
Specialty Coating Systems, Inc. |
Medical devices and methods of preparation and use
|
|
US20060194821A1
(en)
*
|
2005-02-18 |
2006-08-31 |
The Brigham And Women's Hospital, Inc. |
Compounds inhibiting the aggregation of superoxide dismutase-1
|
|
US9107899B2
(en)
|
2005-03-03 |
2015-08-18 |
Icon Medical Corporation |
Metal alloys for medical devices
|
|
US20060201601A1
(en)
*
|
2005-03-03 |
2006-09-14 |
Icon Interventional Systems, Inc. |
Flexible markers
|
|
WO2006110197A2
(en)
|
2005-03-03 |
2006-10-19 |
Icon Medical Corp. |
Polymer biodegradable medical device
|
|
ES2986867T3
(es)
|
2005-03-03 |
2024-11-12 |
Mirus Llc |
Aleaciones metálicas mejoradas para dispositivos médicos
|
|
US20060264914A1
(en)
*
|
2005-03-03 |
2006-11-23 |
Icon Medical Corp. |
Metal alloys for medical devices
|
|
US7540995B2
(en)
|
2005-03-03 |
2009-06-02 |
Icon Medical Corp. |
Process for forming an improved metal alloy stent
|
|
US20060200048A1
(en)
*
|
2005-03-03 |
2006-09-07 |
Icon Medical Corp. |
Removable sheath for device protection
|
|
US8323333B2
(en)
*
|
2005-03-03 |
2012-12-04 |
Icon Medical Corp. |
Fragile structure protective coating
|
|
EP1904480A2
(en)
|
2005-05-23 |
2008-04-02 |
Novartis Pharma AG |
Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
|
|
CN101365446B
(zh)
|
2005-07-29 |
2013-05-22 |
雷斯弗洛吉克斯公司 |
预防和治疗复杂疾病的药物组合物及其经由可植入医药装置的递送
|
|
JP2009521470A
(ja)
|
2005-12-23 |
2009-06-04 |
リンク メディシン コーポレイション |
シヌクレイン障害の治療
|
|
US20070148390A1
(en)
*
|
2005-12-27 |
2007-06-28 |
Specialty Coating Systems, Inc. |
Fluorinated coatings
|
|
ATE547394T1
(de)
|
2006-12-01 |
2012-03-15 |
Bristol Myers Squibb Co |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
|
|
DK2118074T3
(en)
|
2007-02-01 |
2014-03-10 |
Resverlogix Corp |
Compounds for the prevention and treatment of cardiovascular diseases
|
|
JP2010528034A
(ja)
*
|
2007-05-23 |
2010-08-19 |
アラーガン、インコーポレイテッド |
医薬としての（（フェニル）イミダゾリル）メチルキノリニル化合物
|
|
US8232402B2
(en)
*
|
2008-03-12 |
2012-07-31 |
Link Medicine Corporation |
Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
|
|
ES2532402T3
(es)
|
2008-06-26 |
2015-03-26 |
Resverlogix Corporation |
Métodos de preparación de derivados de quinazolinona
|
|
US20100331363A1
(en)
*
|
2008-11-13 |
2010-12-30 |
Link Medicine Corporation |
Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
|
|
WO2010057006A1
(en)
*
|
2008-11-13 |
2010-05-20 |
Link Medicine Corporation |
Azaquinolinone derivatives and uses thereof
|
|
US20110060005A1
(en)
*
|
2008-11-13 |
2011-03-10 |
Link Medicine Corporation |
Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
|
|
JP5635535B2
(ja)
|
2009-01-08 |
2014-12-03 |
レスバーロジックス コーポレイション |
心血管疾患の予防および治療のための化合物
|
|
CN105859639A
(zh)
|
2009-03-18 |
2016-08-17 |
雷斯韦洛吉克斯公司 |
新的抗炎剂
|
|
CN107252429B
(zh)
|
2009-04-22 |
2023-06-16 |
雷斯韦洛吉克斯公司 |
新抗炎剂
|
|
US8398916B2
(en)
|
2010-03-04 |
2013-03-19 |
Icon Medical Corp. |
Method for forming a tubular medical device
|
|
JP5992049B2
(ja)
|
2011-11-01 |
2016-09-14 |
レスバーロジックス コーポレイション |
置換されたキナゾリノンのための経口速放性製剤
|
|
CA2860099A1
(en)
*
|
2012-02-13 |
2013-08-22 |
Johannes Aebi |
Imidazolylketone derivatives asd aldosterone synthase inhibitors
|
|
PE20150778A1
(es)
*
|
2012-10-16 |
2015-05-23 |
Janssen Pharmaceutica Nv |
Moduladores de quinolinilo unidos a metileno de ror-gamma-t
|
|
PE20151203A1
(es)
|
2012-10-16 |
2015-08-31 |
Janssen Pharmaceutica Nv |
MODULADORES DE QUINOLINILO UNIDOS A FENILO DE ROR-GAMMA-t
|
|
KR20150070348A
(ko)
|
2012-10-16 |
2015-06-24 |
얀센 파마슈티카 엔.브이. |
RoRγt의 헤테로아릴 결합 퀴놀리닐 조절제
|
|
WO2014080291A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Biaryl derivatives as bromodomain inhibitors
|
|
WO2014080290A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Cyclic amines as bromodomain inhibitors
|
|
AU2013365926B9
(en)
|
2012-12-21 |
2019-01-17 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
US10555941B2
(en)
|
2013-10-15 |
2020-02-11 |
Janssen Pharmaceutica Nv |
Alkyl linked quinolinyl modulators of RORγt
|
|
US9284308B2
(en)
|
2013-10-15 |
2016-03-15 |
Janssen Pharmaceutica Nv |
Methylene linked quinolinyl modulators of RORγt
|
|
US9624225B2
(en)
|
2013-10-15 |
2017-04-18 |
Janssen Pharmaceutica Nv |
Quinolinyl modulators of RORγt
|
|
US9346782B2
(en)
|
2013-10-15 |
2016-05-24 |
Janssen Pharmaceutica Nv |
Alkyl linked quinolinyl modulators of RORγt
|
|
US9221804B2
(en)
|
2013-10-15 |
2015-12-29 |
Janssen Pharmaceutica Nv |
Secondary alcohol quinolinyl modulators of RORγt
|
|
US9403816B2
(en)
|
2013-10-15 |
2016-08-02 |
Janssen Pharmaceutica Nv |
Phenyl linked quinolinyl modulators of RORγt
|
|
US9328095B2
(en)
|
2013-10-15 |
2016-05-03 |
Janssen Pharmaceutica Nv |
Heteroaryl linked quinolinyl modulators of RORgammat
|
|
US11311519B2
(en)
|
2014-05-01 |
2022-04-26 |
Eiger Biopharmaceuticals, Inc. |
Treatment of hepatitis delta virus infection
|
|
US10076512B2
(en)
|
2014-05-01 |
2018-09-18 |
Eiger Biopharmaceuticals, Inc. |
Treatment of hepatitis delta virus infection
|
|
EP3160397A4
(en)
|
2014-06-24 |
2018-03-21 |
Icon Medical Corp. |
Improved metal alloys for medical devices
|
|
CA2972771C
(en)
*
|
2014-12-18 |
2024-06-11 |
University Of South Carolina |
Suppression of neointimal formation following vascular surgery using cdk8 inhibitors
|
|
CN114984016A
(zh)
|
2015-03-13 |
2022-09-02 |
雷斯韦洛吉克斯公司 |
用于治疗补体相关疾病之组合物及治疗方法
|
|
CN107530338B
(zh)
|
2015-04-21 |
2020-12-01 |
艾格尔峰生物制药有限公司 |
包含洛那法尼和利托那韦的药物组合物
|
|
CN107787373B
(zh)
|
2015-08-17 |
2021-11-26 |
库拉肿瘤学公司 |
法尼基转移酶抑制剂在制备用于治疗癌症的药物中的用途
|
|
EP3389652B1
(en)
|
2015-12-14 |
2022-09-28 |
X4 Pharmaceuticals, Inc. |
Methods for treating cancer
|
|
US10953003B2
(en)
|
2015-12-14 |
2021-03-23 |
X4 Pharmaceuticals, Inc. |
Methods for treating cancer
|
|
ES2935834T3
(es)
|
2015-12-22 |
2023-03-10 |
X4 Pharmaceuticals Inc |
Métodos para tratar enfermedad de inmunodeficiencia
|
|
US11766506B2
(en)
|
2016-03-04 |
2023-09-26 |
Mirus Llc |
Stent device for spinal fusion
|
|
CA3019394A1
(en)
|
2016-04-08 |
2017-10-12 |
X4 Pharmaceuticals, Inc. |
Methods for treating cancer
|
|
CN109640988A
(zh)
|
2016-06-21 |
2019-04-16 |
X4 制药有限公司 |
Cxcr4抑制剂及其用途
|
|
CN109562106B
(zh)
|
2016-06-21 |
2023-03-21 |
X4 制药有限公司 |
Cxcr4抑制剂及其用途
|
|
WO2017223243A1
(en)
|
2016-06-21 |
2017-12-28 |
X4 Pharmaceuticals, Inc. |
Cxcr4 inhibitors and uses thereof
|
|
HUE053927T2
(hu)
|
2016-11-03 |
2021-07-28 |
Kura Oncology Inc |
Farneziltranszferáz inhibitorok rák kezelésében történõ alkalmazásra
|
|
US10548889B1
(en)
|
2018-08-31 |
2020-02-04 |
X4 Pharmaceuticals, Inc. |
Compositions of CXCR4 inhibitors and methods of preparation and use
|
|
CN110204487B
(zh)
*
|
2019-06-21 |
2021-09-28 |
江南大学 |
一种喹啉衍生物的合成方法
|
|
EP4117662A4
(en)
|
2020-03-10 |
2024-04-03 |
X4 Pharmaceuticals, Inc. |
METHODS OF TREATING NEUTROPENIA
|
|
CN113072490B
(zh)
*
|
2021-03-26 |
2022-08-16 |
中国海洋大学 |
一种替吡法尼喹啉酮中间体的高效合成方法
|
|
CN119371281A
(zh)
*
|
2024-12-27 |
2025-01-28 |
山东石油化工学院 |
一种CH2Cl2参与C-H键活化的烷基氯取代的方法
|